WELCOME MESSAGE
Prof. Humaid Al Shamsi
MD(Hon), MRCP(UK), FRCP(C), FACP
Dear Colleagues and Partners,
It is with great pleasure that I extend a warm welcome to each one of you to the 5th Emirates Oncology Society Annual Conference, scheduled to be held on October 4th, 5th, and 6th, 2024 at Hyatt Regency Creek Heights, Dubai, UAE.
As the President of the Emirates Oncology Society, I am thrilled to invite you to join us for this prestigious gathering of renowned oncology experts, healthcare professionals, researchers, and industry leaders. This conference serves as a platform for knowledge exchange, collaboration, and innovation in the field of oncology.
Our program promises to be enlightening and engaging, featuring insightful keynote presentations, interactive workshops, poster sessions, and networking opportunities. This conference aims to showcase the latest advancements in oncology research, treatment modalities, and patient care, while fostering meaningful discussions and partnerships that drive positive impact in cancer management.
I am confident that your participation will enrich the conference experience and contribute to its success. Together, let us work towards advancing oncology practices, enhancing patient outcomes, and shaping the future of cancer care in the UAE and beyond.
I look forward to welcoming you all at the 5th EOS Annual Conference in Dubai and trust that our time together will be both professionally rewarding and personally fulfilling.
It is with great pleasure that I extend a warm welcome to each one of you to the 5th Emirates Oncology Society Annual Conference, scheduled to be held on October 4th, 5th, and 6th, 2024 at Hyatt Regency Creek Heights, Dubai, UAE.
As the President of the Emirates Oncology Society, I am thrilled to invite you to join us for this prestigious gathering of renowned oncology experts, healthcare professionals, researchers, and industry leaders. This conference serves as a platform for knowledge exchange, collaboration, and innovation in the field of oncology.
Our program promises to be enlightening and engaging, featuring insightful keynote presentations, interactive workshops, poster sessions, and networking opportunities. This conference aims to showcase the latest advancements in oncology research, treatment modalities, and patient care, while fostering meaningful discussions and partnerships that drive positive impact in cancer management.
I am confident that your participation will enrich the conference experience and contribute to its success. Together, let us work towards advancing oncology practices, enhancing patient outcomes, and shaping the future of cancer care in the UAE and beyond.
I look forward to welcoming you all at the 5th EOS Annual Conference in Dubai and trust that our time together will be both professionally rewarding and personally fulfilling.
With warm regards.
Prof. Humaid Al Shamsi
OPENING CEREMONY
HE Dr. Amin Al Ameeri
M.Sc, Ph.D
Assistant Undersecretary for
Health Regulation, UAE
Prof. Humaid Al Shamsi
MD(Hon), MRCP(UK), FRCP(C), FACP
CEO Burjeel Cancer Institute, Burjeel Holding,
President of Emirates Oncology Society,
Professor of Oncology,
RAK Medical and Health Sciences University, UAE
Sheikha Dr. Noura Al Qassimi
President of the Emirates Medical Association,
Consultant in Medical Retina Uveitis, UAE
OUR SPEAKERS
Dr. Abdulmajeed Dayyat
MD, FRCPC
Assistant professor,
at the University of Manitoba,
Radiation Oncologist at CancerCare Manitoba,
Winnipeg, Canada
Dr. Angela Punnett
MD, FRCPC
Associate Professor in Pediatrics and Director,
of Undergraduate Medical Education,
University of Toronto,
Staff Physician, Haematology/Oncology, SickKids, Canada
Staff Physician, Haematology/Oncology, SickKids, Canada
Prof. Dr. Barbara Lawrenz
MD, PhD
Guest professor at the Reproductive Unit UZ Gent, Belgium,
Specialist Reproductive Medicine and Infertility,
Scientific Director, ART Fertility Clinics, UAE
Prof. Christopher Booth
MD, FRCPC
Professor of Medical Oncology,
Canada Research Chair in Population,
Cancer Care Queen’s University, Canada
Dr. Hasan Al Khudairi
MD
Consultant Of Obstetrics, Gynecology,
and Palliative Medicine, King Faisal Specialist
Hospital Research Centre, KSA
Dr. Hind Elmalik
MRCP, RCP ONCOLOGY (UK)
Assistant professor of clinical medicine at WCMQ,
Consultant Medical Oncologist,
National Center for Cancer Care and Research,
Hamad Medical Corporation (HMC), Qatar
Dr. Jean El Cheikh
MD
Associate Professor,
American University of Beirut Medical Center,
Lebanon
Dr. Mohammed Basheeruddin Inamdar
MD
Consultant Surgical Oncologist,
Robotic Surgeon, Burjeel Specialty
Hospital, Sharjah, UAE
Dr. Mohammad Adileh
MD
Consultant Surgical Oncologist,
HAIP program director,
Burjeel Medical City, UAE
Prof. Ola Khorshid
MD, PhD
Department Chair & Prof. of Medical Oncology,
NCI Cairo University, Founder and Chairman,
of Millennium Health Care Company, Egypt
Dr. Otto Metzger
MD
Assistant Professor of Medicine,
Harvard Medical School,
Medical Oncologist,
Dana-Farber Cancer Institute, USA
Dr. Renato Cunha
MD, PhD
National Leader of the Cellular Therapy Program,
Grupo Oncoclínicas,
Investigator at Instituto Oncoclínicas, Brazil
Ms. Rita Gallagher
Pediatric Practice development
Nurse, Dubai Health Authority, UAE
Prof. Salah-Eddin Al-Batran
MD
Board member of the University Cancer Center,
Medical Director, Head of Gastrointestinal Oncology,
Institute of Clinical Cancer Research (IKF), Germany
Prof. Stephen Freedland
MD
Professor of Surgery at Cedars-Sinai Medical Center,
Associate Director of Faculty Development at the,
Samuel Oschin Comprehensive Cancer Institute, USA
Dr. Sumaya Alblooshi
BSN, MSN, PhD, FAAN
President of Emirates Nursing,
Association Director of Nursing,
Emirates Health Services Head of National Committee
for nursing and Midwifery, UAE
Dr. Wael El-Sheshtawy
M.D., M.Sc., Ph.D.
Fellowship Radiation Oncology, McGill University, Canada
Head of Clinical Oncology Department, Al-Azhar University, Egypt
Dr. Mark Verrill
MA, FRCP
Head of Medical Oncology,
Northern Centre for Cancer Care ( NCCC), UK
Prof. Nuhad Ibrahim
MD
Professor, Department of Breast
Medical Oncology, Division of
Cancer Medicine, The University
of Texas MD Anderson Cancer
Center, USA
Dr. Thorsten Fuereder
MD
Medical Oncologist,
Medical University of Vienna,
Austria
Dr. Hampig Kourie
MD, PhD
Assistant Professor,
Hematology oncology department,
Faculty of Medicine,
Saint Joseph University, Lebanon
Dr. Basel Shoua
MD
Hematology and Oncology Specialist,
University of Arizona in Tucson,
USA
Dr. Lorenza Landi
MD
Director of Clinical Trials Unit: Phase 1 and
Precision Medicine at the National
Cancer Institute “Regina Elena” in Rome, Italy
Dr. Arafat Tfayli
MD
Associate Professor of Clinical Medicine,
The American University of Beirut,
Lebanon
Prof. Abdelmotaleb Mohamed
MD
Professor at Zagazig University,
Egypt
Dr. Pinaki Bose
MD
Co-founder and Executive Vice President of OncoHelix
Associate Professor
University of Calgary, Canada
Dr. Majed Alghamdi
MD, MBA, FRCPC, DABR
Consultant, and Assistant Professor of Radiation Oncology, KSA
Prof. Debasish Tripathy
MD
Professor and Chairman, Department of Breast Medical Oncology,
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, USA
Prof. Giuseppe Curigliano
MD
Clinical Director Division of Early Drug Development for Innovative Therapy Co-Chair Cancer Experimental Therapeutics Program Department of Oncology and Hemato-Oncology, University of Milan European Institute of Oncology, Italy
OUR FACULTY
Prof. Humaid Al Shamsi
MD(Hon), MRCP(UK), FRCP(C), FACP
CEO Burjeel Cancer Institute,
Burjeel Holding, President of Emirates Oncology Society,
Professor of Oncology, RAK Medical and Health Sciences University, UAE
Dr. Aydah Al Awadhi
MD
EOS Scientific Committee Chairperson,
Consultant Medical Oncologist,
Chair of Haematology and Oncology Division,
Sheikh Shakhbout Medical City, UAE
Dr. Saeed Rafii
MD, PhD, MRCP, MRCP,CCT, FRCP
Consultant Medical Oncologist,
EOS General Secretary,
Mediclinic Hospital, UAE
Dr. Dalia Elshorbagy
MD, BC
Consultant Medical Oncology,
Sheikh Shakhbout Medical City,
UAE
Dr. Emad Dawoud
MD
Consultant Medical Oncology,
Tawam Hospital, UAE
Dr. Dina Hamza
MD, BC
Consultant Medical Oncology,
Dubai Health,
Dubai Hospital, UAE
Dr. Hassan Jaafar
MD
Medical Director,
Burjeel Cancer Institute,
Burjeel Medical City, UA
Dr. Ibrahim Abu-Gheida
MD
Clinical Director,
Department of Radiation Oncology,
Burjeel Medical City, UAE
Dr. Fathi Azribi
FRCP, CCT
Consultant Medical Oncologist,
American Hospital,
UAE
Dr. Hassan Ghazal
MD
American Board Certified,
Consultant Oncologist Hematologist.
Kings College Hospital, UAE
Dr. Faek Jamali
MD
Consultant Colorectal Surgeon,
Surgical Oncologist,
SSMC, UAE
Dr. Aref Chehal
MD, MBCHB, FACP, ECMO
Consultant Oncology,
Sheikh Shakhbout Medical City (SSMC), UAE
Dr. Mohammad Adileh
MD
Consultant Surgical Oncologist,
HAIP program director,
Burjeel Medical City, UAE
Dr. Diaeddine Trad
MD
Consultant Medical Oncology,
Tawam Hospital, UAE
Dr. Mohammed Basheeruddin Inamdar
MD
Consultant Surgical Oncologist,
Robotic Surgeon, Burjeel Specialty Hospital,
Sharjah, UAE
Dr. Syed Hammad Tirmazy
MRCP, FRCP, FRCR, MSc, CCT UK
Consultant Clinical Oncologist
Head of Oncology, Dubai Hospital, DHA
EOS Cultural Committee Chairperson,
UAE
Dr. Deborah Mukherji
MBBS, FRCP
Medical Oncologist,
Clemenceau Medical Center, UAE
Dr. Sarfraz Ahmad
MBBS, PhD, MRCS, FRCS (Urol)
Consultant Urological Surgeon,
Director of Robotic Surgery,
Sheikh Shakhbout Medical City (SSMC), UAE
Dr. Maryam Aslani
MD, FRCPC
Consultant Radiation Oncologist,
Canadian Board of Radiation Oncology,
American Board of Radiation Oncology,
Mediclinic City Hospital, UAE
Dr. Jawaher Ansari
MD
Chief of Medical Oncology,
Tawam Hospital, UAE
Dr. Muhammad Farooq Latif
MD, FRCP (Glasg), FRCP (Edin), FRCR (Clinical Oncology),
Consultant Medical Oncologist,
Dubai Health,
UAE
Dr. Mehdi Afrit
MD
Medical Oncologist,
Medical Director,
Burjeel Speciality Hospital, UAE
Dr. Hassan Shahryar
MD
Consultant Hematology and Oncology,
Sheikh Shakhbout Medical City,
Abu Dhabi, UAE
Dr. Abdul Rahman El Kinge
MD
Head of the Department
of Hematology Medical Oncology,
NMC Royal Sharjah, UAE
Dr. Maroun El Khoury
MD
Chief of Cancer Center,
Chief Quality Officer and Oncologist/Hematologist
American Hospital Dubai, Oud Metha, UAE
Dr. Amin Abyad
MD
Hematology Oncology ,
Burjeel Cancer Institute, UAE
Dr. Rana Irfan Mahmood
FRCP (Glasgow), FRCP (Ireland), FRCR (UK),
CCT in Clinical Oncology (UK)
Consultant Oncologist & Clinical Lead, Adj Associate Professor MBRU,
Comprehensive Cancer Centre, Mediclinic City Hospital, UAE
Dr. Rasha Mustafa
MD
EOS Palliative and Supportive Care Working Group Secretary,
Specialist in Palliative Medicine,
Burjeel Medical City, Abu Dhabi, UAE
Dr. Neil Nijhawan
BSc (Hons), PhD MMBBS (UK), MRCP (UK), CCT UK, FRCP(UK)
Consultant HOD, Pain and Palliative,
Director of Clinical Governance in CMO Office, UAE
Ms. Rita Gallagher
Pediatric Practice development
Nurse, Dubai Health Authority UAE
Dr. Mona Al-Ayyan
MD
Breast Surgeon,
Saqr Hospital,
UAE
Prof. Marwan Ghosn
MD, MHHM
Consultant Medical Oncology,
Clemenceau Medical Center Hospital,
UAE
Prof. Ernest Luiten
MD, PhD, FDCS, FDSSO
Consultant Oncoplastic Breast Surgeon,
Adjunct Associate Professor Surgery, College of Medicine and Health Sciences, UAE University, Acting Chief of Breast Cancer Surgery, Tawam Hospital, UAE
Dr. Nouri Bennini
MD
Consultant Medical Oncology
Tawam Hospital,
UAE
Dr. Mohammed Al Nuaimi
MD
Pediatric Hematologist & Oncologist,
Bone Marrow Transplant and Cellular Therapy Tawam Hospital,
Abu Dhabi, UAE
Dr. Eman Al Shamsi
MD, PhD
Consultant Pediatric Onco/Hematologist,
Al Jaleela Hospital, UAE
Dr. Charbel Khalil
MD
Stem Cell Therapist
Burjeel Medical City, UAE
Dr. Nathalie Jacque
MD
Consultant Hematologist,
Clemenceau Medical Center Hospital, UAE
Dr. Amna Al Mehairi
MD
Consultant Hematology,
Dubai Health , UAE
Dr. Shabeeha Rana
MBBS, MRCP, FRCPath, CCT
Consultant Haematologist, King’s College Hospital London, UAE
Dr. Sumaya Alblooshi
BSN, MSN, PhD, FAAN
President of Emirates Nursing Association,
Director of Nursing, Emirates Health Services,
Head of National Committee for Nursing and Midwifery, UAE
AWARDS
EOS TOP 3 BEST ABSTRACT
Association of CSMD3
Mutation with Response to
Immune Checkpoint Inhibitors
Mutation with Response to
Immune Checkpoint Inhibitors
Conserved role of FOXC1 in
TNBC is parallel to FOXA1 in
ER+ breast cancer
TNBC is parallel to FOXA1 in
ER+ breast cancer
A case for investing in
women’s cancers in the
Eastern Mediterranean Region
women’s cancers in the
Eastern Mediterranean Region
Medical Student
Saint Joseph University of Beirut,
Lebanon Hotel Dieu De France, Beirut,
Lebanon
4th year PhD student at
the Mohammed bin Rashid University
of Medicine and Health Sciences
Regional Adviser Women's Health
World Health Organization
Eastern Mediterranean Regional Office
Cairo, Egypt
GALLERY
Day 1
Day 2
Day 3
PRESS & MEDIA
GO GREEN
EOS Dedication to Sustainability
To boost environmental responsibility,
we are adopting six key steps for Sustainability
OUR SPONSORS
